DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Nolvadex (Tamoxifen) - Retinal Detachment - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Retinal Detachment (3)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Nolvadex (Tamoxifen) where reactions include retinal detachment. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Nolvadex side effects in female

Reported by a physician from Japan on 2012-07-02

Patient: female, weighing 47.0 kg (103.4 pounds)

Reactions: Retinal Detachment

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Nolvadex
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-05-14

Zoladex
    Indication: Breast Cancer
    Start date: 2012-05-14



Possible Nolvadex side effects in 30 year old female

Reported by a physician from Japan on 2012-05-31

Patient: 30 year old female

Reactions: Retinal Detachment

Drug(s) suspected as cause:
Zoladex
    Indication: Breast Cancer

Nolvadex
    Administration route: Oral
    Indication: Breast Cancer



Possible Nolvadex side effects in 57 year old female

Reported by a physician from Austria on 2012-05-04

Patient: 57 year old female

Reactions: Retinal Detachment

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Arimidex
    Administration route: Oral
    Start date: 2007-01-01

Faslodex
    Dosage: monthly
    Indication: Breast Cancer
    Start date: 2007-10-01
    End date: 2010-04-01

Nolvadex
    Administration route: Oral
    Start date: 2005-05-01
    End date: 2006-06-01

Femara
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2006-06-01
    End date: 2007-10-01

Other drugs received by patient: Methotrexate

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017